Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease

Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.

Detalles Bibliográficos
Autores principales: Yee, Marianne E. M., Batsuli, Glaivy, Chonat, Satheesh, Park, Sunita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813102/
https://www.ncbi.nlm.nih.gov/pubmed/33489197
http://dx.doi.org/10.1002/ccr3.3556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813102/
https://www.ncbi.nlm.nih.gov/pubmed/33489197
http://dx.doi.org/10.1002/ccr3.3556

Ejemplares similares